693-20609-42377

4 vaccinations 20 coded responses 39 check-ins 19 free-text entries 9 call cases

Sex: Female
Age at first dose: 66+
ZIP prefix: 880 / NM
Registered: 2021-01-16

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-14
Dose 1 — Pfizer-BioNTech
2021-01-16
Registered in v-safe
2021-01-16
Survey response — days 1–6 daily, dose 1
MedDRA: Asthenia, Tachycardia — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Weakness, intermittent tachycardia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-18
Survey response — days 1–6 daily, dose 1
MedDRA: Asthenia, Tachycardia — Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Weakness, intermittent tachycardia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-18
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-21
Health check-in — day 7, dose 1
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-02-04
Dose 2 — Pfizer-BioNTech
2021-02-04
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-02-05
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-02-06
Survey response — days 1–6 daily, dose 2
MedDRA: Asthenia, Tachycardia — Feeling: Fair · Fever · Be unable to do your normal daily activities

Free text: Intermittent Tachycardia, severe weakness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-07
Survey response — days 1–6 daily, dose 2
MedDRA: Tachycardia — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Tachycardia with ambulation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-08
Survey response — days 1–6 daily, dose 2
MedDRA: Asthenia, Tachycardia — Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Weakness & tachycardia with ambulation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-09
Survey response — days 1–6 daily, dose 2
MedDRA: Tachycardia — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Tachycardia with ambulation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-10
Survey response — days 1–6 daily, dose 2
MedDRA: Tachycardia — Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Tachycardia with ambulation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-11
Survey response — day 7, dose 2
MedDRA: Asthenia, Tachycardia — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Weakness & tachycardia with ambulation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-18
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-02-25
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-03-06
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-13
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-03-20
Survey response — day 42, dose 2
MedDRA: Herpes virus infection, Hyperglycaemia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Hyperglycemia Herpes outbreak

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-20
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-06
Survey response — 3 months, dose 2
MedDRA: Extrasystoles, Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Intermittent tachycardia with dropped beats

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-06
Report sent to call center — 3 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-11
Call 2 — Left Voicemail
2021-08-05
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2021-10-01
Dose 3 — Pfizer-BioNTech
2021-10-02
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-10-03
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-10-04
Survey response — days 1–6 daily, dose 3
MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Woke up and my nightgown and sheets were all wet from sweat

MedDRA releases: 2024-11 · check-in free text available
2021-10-05
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-10-06
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-10-07
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Redness, Swelling · Fever · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-10-08
Survey response — day 7, dose 3
MedDRA: Eye pain, Oropharyngeal pain — Feeling: Fair · Site: Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Sore throat, eye pain

MedDRA releases: 2024-11 · check-in free text available
2021-10-15
Survey response — day 14, dose 3
MedDRA: Abdominal pain, Chills, Dyspnoea, Eye pain, Fatigue, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Feverish, some chills;right side of my face hurts, eyes hurt, was Short of breath yesterday and today. Very tired and fatigued.

MedDRA releases: 2024-11 · check-in free text available
2021-10-22
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2021-10-29
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2021-11-05
Survey response — day 35, dose 3
MedDRA: Dyspepsia, Fatigue — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Constant heartburn even after medication Fatigue

MedDRA releases: 2024-11 · check-in free text available
2021-11-12
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2021-12-31
Health check-in — 3 months, dose 3
Feeling: Fair

Adult check-in
2022-04-01
Survey response — 6 months, dose 3
MedDRA: Nephrolithiasis, Nephropathy, Pain, Renal cyst, Renal impairment — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: I have been diagnosed with kidney disease with 40% kidney function; chronic pain with kidney stones & cysts.

MedDRA releases: 2024-11 · check-in free text available
2022-04-01
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-04
Call successful
Does not wish to fill out VAERS report
2022-04-04
Call successful
Does not wish to fill out VAERS report
2022-04-04
Call successful
Does not wish to fill out VAERS report
2022-04-19
Dose 4 — Pfizer-BioNTech
2022-05-14
Survey response — day 21, dose 4
MedDRA: Fatigue, Nausea, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Nausea/Vomiting Severe fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-05-14
Report sent to call center — day 21, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-16
Call 1 — Requested Callback
2022-05-16
Call 1 — Requested Callback
2022-05-16
Call 1 — Requested Callback
2022-05-16
Call 1 — Requested Callback
2022-05-17
Survey response — day 28, dose 4
MedDRA: Dizziness, Fatigue, Nausea, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Nausea/vomiting, dizziness and fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-05-24
Survey response — day 35, dose 4
MedDRA: Asthenia, Dizziness, Fatigue — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: N/V fatigue & weakness, dizziness- taking Zofran PO

MedDRA releases: 2024-11 · check-in free text available
2022-05-24
Report sent to call center — day 35, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-24
Call 2 — Left Voicemail
2022-05-24
Callback requested for
2022-05-24
Call 1 — Left Voicemail
2022-05-31
Health check-in — day 42, dose 4
Feeling: Fair

Adult check-in
2022-07-19
Survey response — 3 months, dose 4
MedDRA: Chills, Myalgia, Nausea, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Chills, Fevers, muscle pain, nausea x 5 days

MedDRA releases: 2024-11 · check-in free text available
2022-07-19
Report sent to call center — 3 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-07-20
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-07-20
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-07-20
Call successful
Does not wish to fill out VAERS report
2022-10-21
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in
2023-04-19
Survey response — 12 months, dose 4
MedDRA: Flank pain, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-04-19
Report sent to call center — 12 months, dose 4
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-04-20
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-14	Pfizer-BioNTech
2	2021-02-04	Pfizer-BioNTech
3	2021-10-01	Pfizer-BioNTech	No
4	2022-04-19	Pfizer-BioNTech	No

Call center

9 call center cases

7 successful · 2 priority 2/3 (triaged and no follow up)

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-16

Systemic reaction (other): Weakness, intermittent tachycardia

2021-01-18

Systemic reaction (other): Weakness, intermittent tachycardia

Release 3 — days 1–6 daily, dose 2

2021-02-06

Systemic reaction (other): Intermittent Tachycardia, severe weakness

2021-02-07

Systemic reaction (other): Tachycardia with ambulation

2021-02-08

Systemic reaction (other): Weakness & tachycardia with ambulation

2021-02-09

Systemic reaction (other): Tachycardia with ambulation

Release 4 — days 1–6 daily, dose 2

2021-02-10

Systemic reaction (other): Tachycardia with ambulation

Release 4 — day 7, dose 2

2021-02-11

Systemic reaction (other): Weakness & tachycardia with ambulation

Release 6 — day 42, dose 2

2021-03-20

Symptoms: Hyperglycemia Herpes outbreak

Release 8 — 3 months, dose 2

2021-05-06

Symptoms: Intermittent tachycardia with dropped beats

Release 9 — days 1–6 daily, dose 3

2021-10-04

Systemic reaction (other): Woke up and my nightgown and sheets were all wet from sweat

Release 10 — day 7, dose 3

2021-10-08

Systemic reaction (other): Sore throat, eye pain

Release 10 — day 14, dose 3

2021-10-15

Symptoms: Feverish, some chills;right side of my face hurts, eyes hurt, was Short of breath yesterday and today. Very tired and fatigued.

Release 10 — day 35, dose 3

2021-11-05

Symptoms: Constant heartburn even after medication Fatigue

Release 11 — 6 months, dose 3

2022-04-01

Symptoms: I have been diagnosed with kidney disease with 40% kidney function; chronic pain with kidney stones & cysts.

Release 11 — day 21, dose 4

2022-05-14

Symptoms: Nausea/Vomiting Severe fatigue

Release 11 — day 28, dose 4

2022-05-17

Symptoms: Nausea/vomiting, dizziness and fatigue

Release 11 — day 35, dose 4

2022-05-24

Symptoms: N/V fatigue & weakness, dizziness- taking Zofran PO

Release 12 — 3 months, dose 4

2022-07-19

Symptoms: Chills, Fevers, muscle pain, nausea x 5 days

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal pain	·	·	✓
SD	Asthenia	·	·	✓
SD	Chills	·	·	✓
SD	Dizziness	·	·	✓
SD	Dyspepsia	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Extrasystoles	✓	✓	✓
SD	Eye pain	·	·	✓
SD	Fatigue	·	·	✓
SD	Flank pain	·	·	✓
SD	Herpes virus infection	✓	✓	✓
SD	Hyperglycaemia	✓	✓	✓
SD	Myalgia	·	·	✓
SD	Nausea	·	·	✓
SD	Nephrolithiasis	·	·	✓
SD	Nephropathy	·	·	✓
SD	Pain	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Pyrexia	·	·	✓
SD	Renal cyst	·	·	✓
SD	Renal impairment	·	·	✓
SD	Tachycardia	✓	✓	✓
SD	Vomiting	·	·	✓
SRO	Asthenia	✓	✓	✓
SRO	Eye pain	·	·	✓
SRO	Hyperhidrosis	·	·	✓
SRO	Oropharyngeal pain	·	·	✓
SRO	Tachycardia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release